FDA Should Curb DTC Ads To Save Reputation – Former FDAer
This article was originally published in The Tan Sheet
Executive Summary
Pharmaceutical companies should work with FDA to tone down direct-to-consumer advertising, which is now considered a "visible concern," according to a former FDA official
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning